Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Medtronic
AstraZeneca
Merck
McKesson
Colorcon

Generated: March 26, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for CUDC-907

« Back to Dashboard

US Patents for CUDC-907

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
CUDC-907 ➤ Try a Free Trial Phosphoinositide 3-kinase inhibitors with a zinc binding moiety Curis, Inc. (Lexington, MA) ➤ Try a Free Trial
CUDC-907 ➤ Try a Free Trial Phosphoinositide 3-kinase inhibitor with a zinc binding moiety Curis, Inc. (Lexington, MA) ➤ Try a Free Trial
CUDC-907 ➤ Try a Free Trial Phosphoinositide 3-kinase inhibitors with a zinc binding moiety Curis, Inc. (Lexington, MA) ➤ Try a Free Trial
CUDC-907 ➤ Try a Free Trial Phosphoinositide 3-kinase inhibitor with a zinc binding moiety Curis, Inc. (Lexington, MA) ➤ Try a Free Trial
CUDC-907 ➤ Try a Free Trial System and method of producing volatile organic compounds from fungi ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for CUDC-907

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
CUDC-907 Australia 2010203512 2029-01-08 ➤ Try a Free Trial
CUDC-907 Brazil PI1004899 2029-01-08 ➤ Try a Free Trial
CUDC-907 Canada 2749228 2029-01-08 ➤ Try a Free Trial
CUDC-907 China 102341108 2029-01-08 ➤ Try a Free Trial
CUDC-907 Cyprus 1116797 2029-01-08 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Julphar
Queensland Health
UBS
Cantor Fitzgerald
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
 NCE-1 Generic Application Dates 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: